ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization

被引:169
作者
DiDonato, M
Craig, L
Huff, ME
Thayer, MM
Cardoso, RMF
Kassmann, CJ
Lo, TP
Bruns, CK
Powers, ET
Kelly, JW
Getzoff, ED
Tainer, JA
机构
[1] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
ALS; Lou Gehrig's disease; superoxide dismutase; aggregation; neurodegenerative;
D O I
10.1016/S0022-2836(03)00889-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many point mutations in human Cu,Zn superoxide dismutase (SOD) cause familial amyotrophic lateral sclerosis (FALS), a fatal neurodegenerative disorder in heterozygotes. Here we show that these mutations cluster in protein regions influencing architectural integrity. Furthermore, crystal structures of SOD wild-type and FALS mutant H43R proteins uncover resulting local framework defects. Characterizations of beta-barrel (H43R) and dimer interface (A4V) FALS mutants reveal reduced stability and drastically increased aggregation propensity Moreover, electron and atomic force microscopy indicate that these defects promote the formation of filamentous aggregates. The filaments resemble those seen in neurons of FALS patients and bind both Congo red and thioflavin T, suggesting the presence of amyloid-like, stacked beta-sheet interactions. These results support free-cysteine-independent aggregation of FALS mutant SOD as an integral part of FALS pathology. They furthermore provide a molecular basis for the single FALS disease phenotype resulting from mutations of diverse side-chains throughout the protein: many FALS mutations reduce structural integrity, lowering the energy barrier for fibrous aggregation. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:601 / 615
页数:15
相关论文
共 76 条
  • [1] ABERNETHY JL, 1974, J BIOL CHEM, V249, P7339
  • [2] Andersen PM, 2001, AMYOTROPH LATERAL SC, V2, pS37
  • [3] Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
  • [4] The Protein Data Bank
    Berman, HM
    Battistuz, T
    Bhat, TN
    Bluhm, WF
    Bourne, PE
    Burkhardt, K
    Iype, L
    Jain, S
    Fagan, P
    Marvin, J
    Padilla, D
    Ravichandran, V
    Schneider, B
    Thanki, N
    Weissig, H
    Westbrook, JD
    Zardecki, C
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 899 - 907
  • [5] Function of the Greek key connection analysed using circular permutants of superoxide dismutase
    Boissinot, M
    Karnas, S
    Lepock, JR
    Cabelli, DE
    Tainer, JA
    Getzoff, ED
    Hallewell, RA
    [J]. EMBO JOURNAL, 1997, 16 (09) : 2171 - 2178
  • [6] Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
    Booth, DR
    Sunde, M
    Bellotti, V
    Robinson, CV
    Hutchinson, WL
    Fraser, PE
    Hawkins, PN
    Dobson, CM
    Radford, SE
    Blake, CCF
    Pepys, MB
    [J]. NATURE, 1997, 385 (6619) : 787 - 793
  • [7] CONSERVED PATTERNS IN THE CU,ZN SUPEROXIDE-DISMUTASE FAMILY
    BORDO, D
    DJINOVIC, K
    BOLOGNESI, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 238 (03) : 366 - 386
  • [8] BOWLING AC, 1995, J NEUROCHEM, V64, P2366
  • [9] ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
    Bruijn, LI
    Becher, MW
    Lee, MK
    Anderson, KL
    Jenkins, NA
    Copeland, NG
    Sisodia, SS
    Rothstein, JD
    Borchelt, DR
    Price, DL
    Cleveland, DW
    [J]. NEURON, 1997, 18 (02) : 327 - 338
  • [10] Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
    Bruijn, LI
    Houseweart, MK
    Kato, S
    Anderson, KL
    Anderson, SD
    Ohama, E
    Reaume, AG
    Scott, RW
    Cleveland, DW
    [J]. SCIENCE, 1998, 281 (5384) : 1851 - 1854